Dorian therapeutics
AcquiredNew therapeutics to rejuvenate tissue and treat age-related diseases
San Carlos, United States · Founded 2018 · $170K raised
- Headquarters
- San Carlos, California
- Employees
- 1–10
- Founded
- 2018
- Website
- doriantherapeutics.com
- Total Funding
- $170K
- Last Round
- $170K GrantMay 2025
- Rounds
- 3
About
New therapeutics to rejuvenate tissue and treat age-related diseases
Summary
Dorian therapeutics is a Biotech company based in San Carlos, United States, founded in 2018. It has raised $170K in total across 3 rounds, most recently a $170K Grant round in May 2025. Investors include Stanford University, Y Combinator Continuity Fund and Blumberg Capital.
Tech & App Stack
2 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
May 2025
Sign up to see all 4 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...
China's leading mRNA biotech company developing therapeutics for cancer and infectious diseases.
Biopharmaceutical company developing and commercializing RNAi therapeutics to treat genetically d...
Clinical-stage programmable cell therapy company developing engineered T-cell therapies for solid...
Clinical-stage biotech developing next-generation CAR T-cell therapies for cancer patients aiming...
Global contract research organization providing comprehensive drug development and laboratory ser...